M. Lind

629 total citations
21 papers, 484 citations indexed

About

M. Lind is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, M. Lind has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Reproductive Medicine. Recurrent topics in M. Lind's work include Ovarian cancer diagnosis and treatment (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Glioma Diagnosis and Treatment (2 papers). M. Lind is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Glioma Diagnosis and Treatment (2 papers). M. Lind collaborates with scholars based in United Kingdom, Germany and Australia. M. Lind's co-authors include P M Wilkinson, Helen Doll, Deborah Cruickshank, D Wild, N Stuart, Crispin Jenkinson, C. C. Vernon, Tim Littlewood, Hunter Newman and Robert A. Grant and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

M. Lind

19 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Lind United Kingdom	13	241	143	94	90	70	21	484
I. Mandjes Netherlands	4	294 1.2×	56 0.4×	94 1.0×	48 0.5×	32 0.5×	4	408
Stuart J. Tipping United States	6	297 1.2×	60 0.4×	141 1.5×	80 0.9×	49 0.7×	9	584
Nadine Haddad United States	11	110 0.5×	102 0.7×	246 2.6×	83 0.9×	92 1.3×	30	591
Antonio Marrazzo Italy	14	282 1.2×	129 0.9×	151 1.6×	116 1.3×	231 3.3×	39	724
Ana Herrero Spain	14	217 0.9×	28 0.2×	112 1.2×	125 1.4×	137 2.0×	41	591
Paraskevi Roussou Greece	13	138 0.6×	83 0.6×	100 1.1×	75 0.8×	28 0.4×	21	528
Gabriel Wcisło Poland	9	115 0.5×	59 0.4×	126 1.3×	73 0.8×	82 1.2×	30	395
Cristina Bilbao Spain	12	101 0.4×	77 0.5×	203 2.2×	63 0.7×	94 1.3×	31	456
Jana Obertová Slovakia	12	155 0.6×	34 0.2×	164 1.7×	149 1.7×	33 0.5×	69	506
Yi Shan China	14	193 0.8×	220 1.5×	231 2.5×	73 0.8×	91 1.3×	53	708

Countries citing papers authored by M. Lind

Since Specialization

Citations

This map shows the geographic impact of M. Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lind more than expected).

Fields of papers citing papers by M. Lind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lind. The network helps show where M. Lind may publish in the future.

Co-authorship network of co-authors of M. Lind

This figure shows the co-authorship network connecting the top 25 collaborators of M. Lind. A scholar is included among the top collaborators of M. Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lind. M. Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeller, Johannes, Nina Chevalier, Laura Schneider, et al.. (2025). C-reactive protein induced T cell activation is an indirect monocyte-dependent mechanism involving the CD80/CD28 pathway. Frontiers in Immunology. 16. 1622865–1622865. 1 indexed citations

Lind, M., et al.. (2025). Picrosirius Red Staining for Semiquantitative Histopathologic Evaluation of Collagen Deposition in Murine Models of Chronic Lung Allograft Rejection. Journal of Visualized Experiments.

Lind, M., Laura Schneider, Jurij Kiefer, et al.. (2025). Differentiation of acute versus chronic skin rejection in a rodent model of vascularized composite allotransplantation. Frontiers in Immunology. 16. 1672754–1672754.

Linstow, Marie‐Louise von, et al.. (2014). Spina bifida and sexuality. Journal of Rehabilitation Medicine. 46(9). 891–897. 31 indexed citations

Rustin, Gordon, Nicholas Reed, Gordon C. Jayson, et al.. (2011). A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. Annals of Oncology. 22(11). 2411–2416. 23 indexed citations

Wilkinson, P M, et al.. (2006). Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial. British Journal of Cancer. 94(7). 947–954. 39 indexed citations

Léonard, Renaud, M. Lind, C.J. Twelves, et al.. (2004). Conventional Adjuvant Chemotherapy Versus Single-Cycle, Autograft-Supported, High-Dose, Late-Intensification Chemotherapy in High-Risk Breast Cancer Patients: A Randomized Trial. JNCI Journal of the National Cancer Institute. 96(14). 1076–1083. 39 indexed citations

Lynch, Thomas J., M. Lind, Aart Brutel de la Rivière, et al.. (2003). O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLC. Lung Cancer. 41. S35–S35. 44 indexed citations

Lind, M., C. C. Vernon, Deborah Cruickshank, et al.. (2002). The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. British Journal of Cancer. 86(8). 1243–1249. 91 indexed citations

10.

White, Jeff, Alison Jones, Christopher Poole, et al.. (2000). A Multicentre Phase II Pilot Study of Epirubicin and Taxol™ (Paclitaxel) in Patients with Advanced Breast Cancer. Clinical Oncology. 12(4). 256–259. 2 indexed citations

11.

Ghazal‐Aswad, Saad, M.J. Tilby, M. Lind, et al.. (1999). Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: Effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels. Annals of Oncology. 10(3). 329–334. 18 indexed citations

12.

Gregor, A., et al.. (1999). Phase II Studies of RMP-7 and Carboplatin in the Treatment of Recurrent High Grade Glioma. Journal of Neuro-Oncology. 44(2). 137–145. 49 indexed citations

13.

Calvert, A H, Jason D. Wright, M. Lind, et al.. (1999). Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene.. PubMed. 26(1 Suppl 2). 90–4. 13 indexed citations

14.

Weaver, Andrew, Jennifer C. Chang, Penella J. Woll, et al.. (1998). Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.. Journal of Clinical Oncology. 16(8). 2601–2612. 31 indexed citations

15.

Gregor, A., et al.. (1997). Phase II study of intravenous RMP-7 and carboplatin for chemotherapy naïve recurrent malignant glioma. European Journal of Cancer. 33. S199–S199. 1 indexed citations

16.

Ghazal‐Aswad, Saad, Linda Hogarth, Andrew G. Hall, et al.. (1996). The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients. British Journal of Cancer. 74(3). 468–473. 23 indexed citations

17.

Bailey, N P, et al.. (1995). 931 Oral folic acid improves lometrexol toxicity profile: A phase I study. European Journal of Cancer. 31. S193–S194. 1 indexed citations

18.

Rafi, Imran, G. A. Taylor, Alan V. Boddy, et al.. (1995). Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion.. PubMed. 1(11). 1275–84. 30 indexed citations

19.

Murphy, Denis J., D. Crowther, J Prendiville, et al.. (1993). A randomised dose intensity study in ovarian carcinoma comparing chemotherapy given at four week intervals for six cycles with half dose chemotherapy given for twelve cycles. Annals of Oncology. 4(5). 377–383. 25 indexed citations

20.

Vries, Elisabeth G.E. de, Thomas C. Hamilton, M. Lind, et al.. (1993). Drug resistance, supportive care and dose intensity. Annals of Oncology. 4. S57–S62. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact